CHECKPOINT THERAPEUTICS INC (CKPT) Stock News

Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates

UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma ...

Mentions: FBIO

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders

Mentions: OPTN COEP SWTX

CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc. - CKPT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders

Mentions: BRDG AKYA QTRX

Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma...

Mentions: FBIO

CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc. - CKPT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, CKPT, AMPY on Behalf of Shareholders

Mentions: FNA AMPY

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq - CKPT), Redfin Corporation (Nasdaq - RDFN), Amplify Energy Corp. (NYSE - AMPY), Blackboxstocks Inc. (Nasdaq - BLBX)

Mentions: RDFN RKT AMPY BLBX

This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Mentions: GPRE LEN AFYA TSVT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CKPT, RDFN, BLBX on Behalf of Shareholders

Mentions: RDFN BLBX

CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma

/PRNewswire/ -- Shareholder law firm Julie & Holleman LLP is investigating the proposed $4.10 per share sale of Checkpoint Therapeutics, Inc. (Nasdaq: CKPT) to...

Mentions: FBIO

Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher

Mentions: RKT RDFN HOOD MLYS ...

CKPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Checkpoint Therapeutics, Inc. Is Fair to Shareholders

Shareholder Alert: The Ademi Firm Investigates Whether Checkpoint Therapeutics, Inc. is Obtaining a Fair Price for Its Public Shareholders

Top India Drugmaker Sun to Buy US Oncology Firm for $355 Million

Sun Pharmaceutical Industries Ltd. has agreed to buy US-based immunotherapy and oncology firm Checkpoint Therapeutics Inc. for an upfront payment of $355 million, as India’s largest drugmaker bolsters its specialty therapy portfolio.